Graham Capital Management’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-16,252
Closed -$720K 1245
2025
Q4
$720K Buy
16,252
+10,391
+177% +$583K 0.02% 489
2025
Q3
$429K Sell
5,861
-30,296
-84% -$1.98M 0.01% 678
2025
Q2
$2.22M Sell
36,157
-20,235
-36% -$1.13M 0.03% 338
2025
Q1
$3.27M Buy
56,392
+22,731
+68% +$1.44M 0.06% 194
2024
Q4
$1.8M Buy
+33,661
New +$1.65M 0.03% 321
2024
Q3
Sell
-22,434
Closed -$627K 1149
2024
Q2
$627K Buy
22,434
+10,922
+95% +$288K 0.01% 512
2024
Q1
$310K Buy
+11,512
New +$328K 0.01% 775
2023
Q2
Sell
-15,270
Closed -$494K 1032
2023
Q1
$494K Buy
+15,270
New +$507K 0.02% 757
2022
Q2
Sell
-15,033
Closed -$783K 1062
2022
Q1
$783K Buy
+15,033
New +$757K 0.03% 394

Other funds holding DOCS

Graham Capital Management's DOCS Position: Q1 2026 in Review

Graham Capital Management sold out of Doximity (DOCS) in Q1 2026, closing a stake of 16,252 shares — an estimated $720K sold.

Graham Capital Management first reported a position in DOCS in Q1 2022 and held it in 9 quarters. The position peaked at $3.27M in Q1 2025. 419 funds tracked by Wall St. Rank hold DOCS as of Q1 2026.

  • Graham Capital Management reported no remaining Doximity position as of Q1 2026 after selling out during the quarter.
  • Graham Capital Management sold 16,252 Doximity shares in Q1 2026, an estimated $720K.
  • Graham Capital Management first reported a position in Doximity in Q1 2022 and held it in 9 quarters.
  • Graham Capital Management's Doximity position peaked at $3.27M in Q1 2025.
  • 419 funds tracked by Wall St. Rank held Doximity as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.